News
Novo Nordisk's FY 2025 guidance cuts are driven by softer U.S. Wegovy/Ozempic and GLP-1 trends. Click here to find out why I ...
Health officials have issued yet another warning over the perils of fake weight loss jabs after an influencer nearly died ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results